Suppr超能文献

受体酪氨酸激酶泛素化涉及衔接蛋白 1 和 Shp2 酪氨酸磷酸酶对 Cbl-Spry2 的动态调节。

Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.

机构信息

Department of Pharmacology, University of Illinois at Chicago, Chicago, Illinois, USA.

出版信息

Mol Cell Biol. 2014 Jan;34(2):271-9. doi: 10.1128/MCB.00850-13. Epub 2013 Nov 11.

Abstract

Ubiquitylation of receptor tyrosine kinases (RTKs) regulates their trafficking and lysosomal degradation. The multidomain scaffolding protein intersectin 1 (ITSN1) is an important regulator of this process. ITSN1 stimulates ubiquitylation of the epidermal growth factor receptor (EGFR) through enhancing the activity of the Cbl E3 ubiquitin ligase. However, the precise mechanism through which ITSN1 enhances Cbl activity is unclear. Here, we demonstrate that ITSN1 interacts with and recruits the Shp2 tyrosine phosphatase to Spry2 to enhance its dephosphorylation, thereby disrupting the inhibitory effect of Spry2 on Cbl and enhancing EGFR ubiquitylation. In contrast, expression of a catalytically inactive Shp2 mutant reversed the effect of ITSN1 on Spry2 dephosphorylation and decreased Cbl-mediated EGFR ubiquitylation. In addition, disruption of ITSN1 binding to Spry2 through point mutation of the Pro-rich ITSN1 binding site in Spry2 resulted in decreased Shp2-Spry2 interaction and enhanced Spry2 tyrosine phosphorylation. This study demonstrates that ITSN1 enhances Cbl activity, in part, by modulating the interaction of Cbl with Spry2 through recruitment of Shp2 phosphatase to the Cbl-Spry2 complex. These findings reveal a new level of complexity in the regulation of RTKs by Cbl through ITSN1 binding with Shp2 and Spry2.

摘要

泛素化受体酪氨酸激酶(RTKs)调节其运输和溶酶体降解。多结构域支架蛋白 intersectin 1(ITSN1)是该过程的重要调节剂。ITSN1 通过增强 Cbl E3 泛素连接酶的活性来刺激表皮生长因子受体(EGFR)的泛素化。然而,ITSN1 增强 Cbl 活性的确切机制尚不清楚。在这里,我们证明 ITSN1 与 Shp2 酪氨酸磷酸酶相互作用并募集到 Spry2 上,以增强其去磷酸化,从而破坏 Spry2 对 Cbl 的抑制作用并增强 EGFR 的泛素化。相比之下,表达无催化活性的 Shp2 突变体逆转了 ITSN1 对 Spry2 去磷酸化的影响,并减少了 Cbl 介导的 EGFR 泛素化。此外,通过 Spry2 中富含脯氨酸的 ITSN1 结合位点的点突变破坏 ITSN1 与 Spry2 的结合,导致 Shp2-Spry2 相互作用减少和 Spry2 酪氨酸磷酸化增强。这项研究表明,ITSN1 通过募集 Shp2 磷酸酶到 Cbl-Spry2 复合物,部分增强了 Cbl 活性,从而调节 Cbl 与 Spry2 的相互作用。这些发现揭示了 Cbl 通过与 Shp2 和 Spry2 结合来调节 RTKs 的新的复杂性。

相似文献

3
Tesk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling.
J Biol Chem. 2008 Jan 18;283(3):1679-1691. doi: 10.1074/jbc.M705457200. Epub 2007 Nov 1.
4
αPIX Is a Trafficking Regulator that Balances Recycling and Degradation of the Epidermal Growth Factor Receptor.
PLoS One. 2015 Jul 15;10(7):e0132737. doi: 10.1371/journal.pone.0132737. eCollection 2015.
5
Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
Mol Pharmacol. 2006 Nov;70(5):1643-53. doi: 10.1124/mol.106.028274. Epub 2006 Aug 16.
8
Cbl controls EGFR fate by regulating early endosome fusion.
Sci Signal. 2009 Dec 22;2(102):ra86. doi: 10.1126/scisignal.2000217.
9
Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts.
J Biol Chem. 2008 Jan 25;283(4):2002-9. doi: 10.1074/jbc.M709046200. Epub 2007 Nov 28.
10
Intersectin 1 forms a complex with adaptor protein Ruk/CIN85 in vivo independently of epidermal growth factor stimulation.
Cell Signal. 2009 May;21(5):753-9. doi: 10.1016/j.cellsig.2009.01.013. Epub 2009 Jan 8.

引用本文的文献

1
Setting sail: Maneuvering SHP2 activity and its effects in cancer.
Adv Cancer Res. 2023;160:17-60. doi: 10.1016/bs.acr.2023.03.003. Epub 2023 Apr 17.
2
A comprehensive review of SHP2 and its role in cancer.
Cell Oncol (Dordr). 2022 Oct;45(5):729-753. doi: 10.1007/s13402-022-00698-1. Epub 2022 Sep 6.
3
Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis.
Nat Cell Biol. 2022 Jan;24(1):35-50. doi: 10.1038/s41556-021-00822-7. Epub 2022 Jan 13.
4
Circulating microRNA profile unveils mechanisms of action of acitretin for psoriasis vulgaris.
Bioengineered. 2021 Dec;12(1):1838-1850. doi: 10.1080/21655979.2021.1925205.
6
Intersectin-1s deficiency in pulmonary pathogenesis.
Respir Res. 2017 Sep 6;18(1):168. doi: 10.1186/s12931-017-0652-4.
7
Intersectin scaffold proteins and their role in cell signaling and endocytosis.
Biochim Biophys Acta Mol Cell Res. 2017 Jan;1864(1):23-30. doi: 10.1016/j.bbamcr.2016.10.005. Epub 2016 Oct 12.

本文引用的文献

2
Nonreceptor tyrosine phosphatase Shp2 promotes adipogenesis through inhibition of p38 MAP kinase.
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):E79-88. doi: 10.1073/pnas.1213000110. Epub 2012 Dec 10.
4
Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis.
Front Med. 2012 Sep;6(3):275-9. doi: 10.1007/s11684-012-0216-4. Epub 2012 Aug 6.
6
Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome.
Neuroreport. 2011 Oct 26;22(15):767-72. doi: 10.1097/WNR.0b013e32834ae348.
8
Bimolecular fluorescence complementation.
J Vis Exp. 2011 Apr 15(50):2643. doi: 10.3791/2643.
9
The tyrosine phosphatase Shp2 in development and cancer.
Adv Cancer Res. 2010;106:53-89. doi: 10.1016/S0065-230X(10)06002-1.
10
Detecting tyrosine-phosphorylated proteins by Western blot analysis.
Curr Protoc Immunol. 2010 Apr;Chapter 11:11.3.1-11.3.11. doi: 10.1002/0471142735.im1103s89.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验